No evidence of association between the synonymous polymorphisms in XRCC1 and ERCC2 and breast cancer susceptibility among nonsmoking Chinese

Gene

Volumn 503, Issue 1, 2012, Pages 118-122

  Yin, Jiaoyang ^a   Wang, Chunhong ^a   Liang, Duohong ^a   Vogel, Ulla ^b   Yue, Li ^c   Liu, Jian ^a   Qi, Rong ^a   Sun, Xiaoling ^d  

^a SHENYANG MEDICAL COLLEGE   (China)

^b NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^c JINZHOU MEDICAL UNIVERSITY   (China)

^d Jinghua Hospital   (China)

Author keywords

Breast cancer; Chinese; ERCC2 Arg156Arg (rs238406); XRCC1 Pro206Pro (rs915927)

Indexed keywords

XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CHINESE; CHROMOSOME 19Q; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 84861790913     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.04.072     Document Type: Article

References (34)

1. Benhamou S., Sarasin A. ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis 2002, 17:463-469.
2. Breast Cancer Association Consortium Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J. Natl. Cancer Inst. 2006, 98:1382-1396.
3. Cagana M., Kilgallen J., Conroy J.M., Wiencke J.K., Kelsey K.T., Miike R., et al. Associations between ERCC2 polymorphisms and gliomas. Cancer Epidemiol. Biomarkers Prev. 2001, 10:355-360.
4. Chang J.S., Wrensch M.R., Hansen H.M., Sison J.D., Aldrich M.C., Quesenberry C.P., et al. Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int. J. Cancer 2008, 123:2095-2104.
5. Dybdahl M., Vogel U., Frentz G., Wallin H., Nexo B.A. Polymorphisms in the DNA repair gene XPD: correlations with risk and at onset of basal cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 1999, 8:77-81.
6. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010, 127:2893-2917.
7. Helzlsouer K.J., Harris E.L., Parshad R., Perry H.R., Price F.M., Sanford K.K. DNA repair proficiency: potential susceptibility factor for breast cancer. J. Natl. Cancer Inst. 1996, 88:754-755.
8. Kipikasová L., Wolaschka T., Bohus P., Baumohlová H., Bober J., Blazejová J., et al. Polymorphisms of the XRCC1 and XPD genes and breast cancer risk: a case-control study. Pathol. Oncol. Res. 2008, 14:131-135.
9. Lamerdin J., Montegomery M., Stilwagen S., Scheidecker L., Tebbs R., Brookman K., et al. Genomic sequence comparison of the human and mouse XRCC1 DNA repair gene regions. Genomics 1995, 25:547-554.
10. Li H., Ha T.C., Tai B.C. XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta-analysis. Breast 2009, 18:183-191.
11. Metsola K., Kataja V., Sillanpää P., Siivola P., Heikinheimo L., Eskelinen M., et al. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Res. 2005, 7:R987-R997.
12. Nexo B.A., Vogel U., Olsen A., Ketelsen T., Bukowy Z., Thomsen B.L., et al. A specific haplotype of single nucleotide polymorphisms on chromosome 19q13.2-3 encompassing the gene RAI is indicative of post-menopausal breast cancer before age 55. Carcinogenesis 2003, 24:899-904.
13. Patel A.V., Calle E., Pavluc A.L., Feigelson H.S., Thun M.J., Rodriguez C. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk. Breast Cancer Res. 2005, 7(R):1168-1173.
14. Ritchie M.D., Hahn L.W., Roodi N., Bailey L.R., Dupont W.D., Parl F.F., et al. Mulltifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am. J. Hum. Genet. 2001, 69:138-147.
15. Ricceri F., Guarrera S., Sacerdote C., Polidoro S., Allione A., Fontana D., et al. ERCC1 haplotypes modify bladder cancer risk: a case-control study. DNA Repair (Amst) 2010, 9:191-200.
16. Rockenbauer E., Bendixen M.H., Bukowy Z., Yin J., Jacobsen N.R., Hedayati M., et al. Association of chromosome 19q13.2-3 haplotypes with basal cell carcinoma: tentative delineation of an involved region using data for single nucleotide polymorphisms in two cohorts. Carcinogenesis 2002, 23:1149-1153.
17. Smith T.R., Levine E.A., Freimanis R.I., Akman S.A., Allen G.O., Hoang K.N., et al. Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis 2008, 29:2132-2138.
18. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005, 15:97-98.
19. Shao J., Gu M., Xu Z., Hu Q., Qian L. Polymorphisms of the DNA gene XPD and risk of bladder cancer in a Southeastern Chinese population. Cancer Genet. Cytogenet. 2007, 177:30-36.
20. Sturgis E.M., Zhen R., Li L., Castillo E.J., Eicher S.A., Chen M., et al. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis 2000, 21:2219-2223.
21. Tomescu D., Kavanagh G., Ha T., Campbell H., Melton D. Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma. Carcinogenesis 2001, 22:403-408.
22. Vogel U., Hedayati M., Dybdahl M., Grossman L., Nexo B.A. Polymorphisms of the DNA repair gene XPD: correlation with risk of basal cell carcinoma revisited. Carcinogenesis 2001, 22:899-904.
23. Vogel U., Olsen A., Wallin H., Overvad K., Tjonneland A., Nexo B.A. Effect of polymorphisms in XPD, RAI, ASE-1 and ERCC1 on the risk of basal cell carcinoma among Caucasians after age 50. Cancer Detect. Prev. 2005, 29:209-214.
24. Vasan R.S. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 2006, 113:2335-2362.
25. Winsey S.L., Harsh N.A., Marsh H.P., Bunce M., Marshall S.E., Harris A.L., et al. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma. Cancer Res. 2000, 60:5612-5616.
26. Wu W., Zhang W., Qiao R., Chen D., Wang H., Wang Y., et al. Association of XPD polymorphisms with severe toxicity in non-small cell lung cancer patients in a Chinese population. Clin. Cancer Res. 2009, 15:3889-3895.
27. Yin J., Liang D., Vogel U., Chang Y., Liu Z., Yue L., et al. The polymorphism of DNA repair gene ERCC2/XPD Arg156Arg and susceptibility to breast cancer in a Chinese population. Biochem. Genet. 2009, 47:582-590.
28. Yin J., Vogel U., Ma Y., Qi R., Sun Z., Wang H. The DNA repair gene XRCC1 and genetic susceptibility of lung cancer in a northeastern Chinese population. Lung Cancer 2007, 56:153-160.
29. Yin J., Vogel U., Ma Y., Qi R., Wang H. Association of DNA repair gene XRCC1 and lung cancer susceptibility among never-smoking Chinese women. Cancer Genet. Cytogenet. 2009, 188:26-31.
30. Yin J., Li J., Ma Y., Guo L., Wang H., Vogel U. The DNA repair gene ERCC2/XPD polymorphism Arg156Arg (A22541C) and risk of lung cancer in a Chinese population. Cancer Lett. 2005, 223:219-226.
31. Yin J., Vogel U., Ma Y., Qi R., Wang H. Haplotypes of nine single nucleotide polymorphisms on chromosome 19q13.2-3 associated with susceptibility of lung cancer in a Chinese population. Mutat. Res. Fundam. Mol. Mech. Mutagen. 2008, 641:12-18.
32. Yin J., Vogel U., Ma Y., Qi R., Wang H. HapMap-based study of the DNA repair gene ERCC2 and lung cancer susceptibility in a Chinese population. Carcinogenesis 2009, 30:1181-1185.
33. Yin J., Rockenbauer E., Hedayati M., Jacobsen N.R., Vogel U., Grossman L., et al. Multiple single nucleotide polymorphisms on human chromosome 19q13.2-3 associate with risk of basal cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1449-1453.
34. Yin J., Vogel U., Gerdes L.U., Dybdahl M., Nexo B.A. Twelve single nucleotide polymorphisms on chromosome 19q13.2-3: linkage disequilibria and associations with basal cell carcinoma in Danish psoriatic patients. Biochem. Genet. 2003, 41:27-37.